Jonathan Amatruda

Jonathan Amatruda, MD, MAS is a Clinical Assistant Professor in the Department of Nephrology at the University of California, San Francisco (UCSF), affiliated with the Zuckerberg San Francisco General Hospital. His clinical practice focuses on general nephrology, including chronic kidney disease, dialysis, and acute kidney injury, with a specific emphasis on patients with concurrent heart disease. His research centers on developing novel biomarkers of kidney health, particularly those linked to kidney tubule function and their role in predicting kidney disease progression.

Education:

• BA in Anthropology, Yale University (2009)
• MD in Medicine, University of Connecticut School of Medicine (2015)
• Internship & Residency in Internal Medicine, Beth Israel Deaconess Medical Center (2018)
• MAS in Clinical Research, UC San Francisco (2021)

His research interests extend to cardiorenal interactions, the impact of medications like NSAIDs on kidney health, and biomarkers predictive of end-stage kidney disease. He has contributed to collaborative projects such as the CKD Biomarkers Consortium and the TRIBE-AKI Consortium. His work bridges clinical practice and translational research, aiming to improve outcomes for patients with kidney and cardiovascular diseases.

Scientific Awards: None explicitly listed.

Advising & Grants: No students or grants mentioned in the provided text. His contributions are primarily through collaborative research initiatives.

Labs & Teams: Affiliated with the UCSF Division of Nephrology, contributing to studies on kidney tubule biomarkers and cardiorenal syndrome.